Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A17, pseudogene (ANKRD20A17P)

Target
ANKRD20A17P
Molecular classification
Other (Pseudogene)
01

Overview

ANKRD20A17P is a human pseudogene from the ankyrin repeat domain 20 family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they arise from gene duplication or retrotransposition. ANKRD20A17P does not encode a functional protein and has no recognized biological roles, disease association, or relevance as a drug target or biomarker. Not a therapeutic target; cannot be manipulated by drugs, antibodies, or other biologics for therapeutic effect. No protein product; does not participate in cell signaling, metabolism, or any biological pathway like functional members of the ankyrin repeat domain family. No known disease relevance; not associated with human disease nor considered a biomarker. If you require information about a functional ankyrin repeat domain-containing protein as a therapeutic target (e.g., ANKRD17, ANKRD1), please specify, as this entry is a pseudogene and not a valid target for drug discovery or translational research.

Other names
Ankyrin repeat domain 20 family member A17, pseudogeneANKRD20A17P
02

Biological functions

Other (No known biological function; pseudogenes typically do not produce functional proteins and have limited or no biological activity)
03

Disease associations

Other (No known disease relevance; no disease associations reported)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A17, pseudogene (ANKRD20A17P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A17, pseudogene (ANKRD20A17P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call